Dr Peter Skarsgard, Vesalius President and Chief Scientific Officer, will be presenting Vesalius TMVr solution during the Innovators Day at EuroPCR in Paris on May 19th, 2022.
We believe mitral valve repair for simple or complex degenerative mitral regurgitation, historically the domain of the surgical super-specialist, will be provided with one percutaneous device during one percutaneous procedure, allowing patients to return to normal activities after relaxing for the weekend after a Friday afternoon cath lab procedure.
Combining two proven surgical techniques in 1 single device delivered to the heart through the femoral vein, Vesalius solution is able to treat simple and complex pathologies of Degenerative Mitral Regurgitation, the most common and fatal heart valve disease. It is reproducing surgery with a catheter.
EuroPCR is the world-leading event in interventional cardiovascular medicine. The Innovators Day features every year a handful of innovative startups with exceptional concepts and techniques.
For more details regarding this event, please click here.